AMERICAN INTERNATIONAL GROUP, INC. - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 117 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.4%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$308,971
-15.8%
56,692
+3.7%
0.00%0.0%
Q2 2023$366,876
-22.8%
54,676
+1.6%
0.00%
-33.3%
Q1 2023$475,142
+17.9%
53,810
+2.0%
0.00%0.0%
Q4 2022$402,926
+6.9%
52,739
-0.4%
0.00%0.0%
Q3 2022$377,000
-10.7%
52,930
+1.4%
0.00%0.0%
Q2 2022$422,000
+1463.0%
52,183
+2555.6%
0.00%
Q1 2022$27,000
-50.9%
1,965
-0.1%
0.00%
Q4 2021$55,000
-20.3%
1,967
-3.4%
0.00%
Q3 2021$69,000
-23.3%
2,036
-7.3%
0.00%
Q2 2021$90,000
+30.4%
2,197
+28.6%
0.00%
Q1 2021$69,000
-38.9%
1,709
-10.7%
0.00%
Q4 2020$113,000
+16.5%
1,914
-4.0%
0.00%
Q3 2020$97,000
+3.2%
1,994
+2.5%
0.00%
Q2 2020$94,000
+141.0%
1,946
+39.8%
0.00%
Q1 2020$39,000
+290.0%
1,392
+300.0%
0.00%
Q4 2019$10,000
-9.1%
348
-3.9%
0.00%
Q3 2019$11,0003620.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2019
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$20,334,21213.72%
BERYLSON CAPITAL PARTNERS, LLC 228,000$1,529,8804.32%
Eagle Health Investments LP 1,214,860$8,151,7111.52%
Matrix Capital Management Company, LP 11,572,590$77,652,0790.90%
Triatomic Management LP 121,166$813,0240.83%
VIKING GLOBAL INVESTORS LP 29,993,708$201,257,7810.82%
Aristotle Atlantic Partners, LLC 3,104,961$20,834,2880.78%
Pier Capital, LLC 737,589$4,949,2220.71%
ARK Investment Management 10,453,752$70,144,6750.46%
Nikko Asset Management Americas, Inc. 6,384,047$42,773,1150.45%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders